Filing Manager
Aron R. English
Reporting Manager
Aron R. English
Symbol
ANEB
Shares outstanding
42,915,616 shares
Disclosed Ownership
21,929,880 shares
Ownership
51%
Form type
SCHEDULE 13D/A
Filing time
27 Feb 2025, 07:41:23 UTC
Date of event
24 Feb 2025
Previous filing
26 Dec 2024

Quoteable Key Fact

"Aron R. English disclosed 51% ownership in Anebulo Pharmaceuticals, Inc. Common Stock, par value $0.001 (ANEB) on 24 Feb 2025."

Quick Takeaways

  • Aron R. English filed SCHEDULE 13D/A for Anebulo Pharmaceuticals, Inc. Common Stock, par value $0.001 (ANEB).
  • Disclosed ownership: 51%.
  • Date of event: 24 Feb 2025.

What Changed

  • Previous schedule filing date: 26 Dec 2024.
  • Current filing was accepted on 27 Feb 2025, 07:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Aron R. English 51% 21,929,880 104,475 21,825,405 /s/ Aron R. English Aron R. English 0001770436
22 NW FUND, LP 40% 17,170,877 0 17,170,877 /s/ Aron R. English Aron R. English, Manager of 22NW Fund GP, LLC, the GP of 22 NW FUND, LP 0001640809
PHARMA INVESTORS, LLC 11% 4,654,528 0 4,654,528 /s/ Aron R. English Aron R. English, Owner
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .